Cargando…
HGG-45. Characterization of spinal diffuse midline gliomas, H3 K28M-mutant
Diffuse midline gliomas (DMGs) are malignant gliomas that arise in the midline structures of the central nervous system. Due to their aggressive and diffuse growth and a two-year survival rate of less than 10%, DMGs are assigned to CNS WHO grade 4. Depending on the localization, median age of patien...
Autores principales: | Stegat, Lotte, Thomas, Christian, Schweizer, Leonille, Neyazi, Sina, Pohl, Lara, Frank, Stephan, Dorostkar, Mario M, Schüller, Ulrich, Wefers, Annika K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165105/ http://dx.doi.org/10.1093/neuonc/noac079.260 |
Ejemplares similares
-
HGG-50. TWO CASES OF H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA OF CERVICAL SPINAL CORD
por: Kuroha, Masae, et al.
Publicado: (2020) -
HGG-03. THE GLYCOSPHINGOLIPIDS METABOLISM IS A NOVEL TARGET IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA
por: Paret, Claudia, et al.
Publicado: (2021) -
HGG-33. Prognostic factors of H3K27M histone-mutant diffuse midline gliomas in patients ≤18yrs
por: Hu, Qingjun, et al.
Publicado: (2022) -
HGG-23. IN VITRO AND IN VIVO PRECLINICAL DRUG SCREENING OF PROMISING THERAPEUTICS FOR DIFFUSE MIDLINE GLIOMA (DMG)
por: Cosentino, Chiara Cianciolo, et al.
Publicado: (2021) -
HGG-15. Generation of a novel mouse model for brain tumors of the DNA methylation class “GBM MYCN”
por: Schoof, Melanie, et al.
Publicado: (2022)